Article Details
Retrieved on: 2023-01-09 17:27:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The move gives AstraZeneca access to CinCor's baxdrostat, an aldosterone synthase inhibitor being investigated for treatment-resistant ...
Article found on: www.mmm-online.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here